🧬 Patient Journey: Crohn’s Disease — inflammation reduced and surgery made possible

Dr. Andrew Peskau
Aug 20
1 min read

Updated: Aug 22

👤 Patient Profile

A 38-year-old man from Italy living with Crohn’s Disease, experiencing chronic intestinal inflammation, complications with bowel function, and structural damage requiring surgical intervention.

🧬 Clinical Approach

In February and April 2024, the patient received a personalised allogeneic regenerative treatment programme at BioCells Medical. The therapy included:

Intravenous infusion of mesenchymal stem cells (MSCs)
Administration of MSCs and purified exosomes for localised anti-inflammatory effect

All cell products were cultivated in BioCells Medical’s certified laboratory and administered under clinical supervision.

📈 Observed Results

Following the two treatment cycles, the patient underwent laboratory testing which confirmed:

Significant reduction in inflammatory markers
Visible clinical improvement, including decreased symptoms and improved intestinal function

These improvements allowed the surgical team to safely proceed with a planned bowel reconnection procedure (recanalisation), which had previously been postponed due to high inflammation risk.

🔁 Follow-up

The patient is recovering post-surgery with stable clinical indicators. No inflammatory relapse has been reported since the procedure. He remains under monitoring with continued support from the BioCells Medical care team.

🌍 About the Programme

At BioCells Medical, patients with chronic inflammatory conditions like Crohn’s disease receive fully individualised regenerative care — including stem cells, exosomes, and immune modulation. All therapies are developed in our certified GMP laboratory in Warsaw and can be delivered in-clinic or abroad.